Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity

Affiliations

¹ Center for the Study of Weapons of Mass Destruction, National Defense University, Washington, DC, 20057, USA.
² Departments of Neurology and Biochemistry and Neuroethics Studies Program-Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC, 20057, USA. james.giordano@georgetown.edu.

Diane DiEuliis et al. Protein Cell. 2018 Mar.

. 2018 Mar;9(3):239-240.

doi: 10.1007/s13238-017-0493-4.

¹ Center for the Study of Weapons of Mass Destruction, National Defense University, Washington, DC, 20057, USA.
² Departments of Neurology and Biochemistry and Neuroethics Studies Program-Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC, 20057, USA. james.giordano@georgetown.edu.

No abstract available

References

1. Clapper J (2016) Director of National Intelligence Statement for the Record, Worldwide Threat Assessment of the US Intelligence Community Senate Armed Services Committee. 9 Feb 2016
1. DiEuliis D, Giordano J. Why gene editors like CRISPR/Cas9 may be a game-changer for neuroweapons. Health Secur. 2017;15(3):296–302. doi: 10.1089/hs.2016.0120. - DOI - PMC - PubMed
1. Gerstein D, Giordano J. Re-thinking the biological toxin and weapons convention? Health Secur. 2017;15(6):1–3. - PMC - PubMed
1. Giordano J. The neuroweapons threat. Bull Atomic Sci. 2016;72(3):1–4.
1. Giordano J. Battlescape brain: engaging neuroscience in defense operations. HDIAC J. 2017;3(4):13–16.